Skip to main content
SpringerLink
Log in

Adalimumab

Miliary tuberculosis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Moyano-Almagro B, et al. Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa. Our clinical experience. Journal of the American Academy of Dermatology 72 (Suppl. 1): AB208 abstr. 1628, No. 5, May 2015. Available from: URL: http://doi.org/10.1016/j.jaad.2015.02.841 [abstract] - Spain

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1556, 19 (2015). https://doi.org/10.1007/s40278-015-2493-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-2493-6

Search

Navigation